Judging by the fact that Protalix BioTherapeutics Inc. (NYSEMKT:PLX) has faced a bearish sentiment from the aggregate hedge fund industry, it’s easy to see that there is a sect of fund managers that slashed their positions entirely by the …
On the HCM Stock Exchange, the VN-Index expanded 2.9 per cent last week ... Energy stocks had positive trades last week when major stocks including PV …
PLx Pharma shares have decreased 48 percent since the beginning ... using data from Zacks Investment Research. Access a Zacks stock report on PLXP at https://www.zacks.com/ap/PLXP
Protalix BioTherapeutics, Inc PLX was a big mover last session, as the company saw its shares rise 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which …
Integrated Device Technology, Inc. Commences Exchange Offer to Acquire PLX Technology, Inc. May 22, 2012 …
Approximately 18.0 million shares, or approximately 40.0% of PLX's outstanding common stock, had been tendered as of 12:00 midnight at the end of the day on October 2, 2012. Correspondingly, in order for the trustee of the PLX Employee …
Dipexium said it will issue about 36 million new shares of its stock to PLx shareholders, who will own just under 77% of outstanding shares while current Dipexium shareholders will own a little over 23%. The new company will retain the …
According to Bloomberg, the offer would be roughly $70 a share in cash and stock that could top $100 billion -- though ... has been growing through acquisitions -- including LSI Corp., PLX Technology, Emulex and others. "The CEO of …